Wednesday, July 01, 2020 7:18:14 AM
MYOS RENS Up 32% After Hours on Merger and Spin-Out Plan
6:39 pm ET June 30, 2020 (Dow Jones) Print
By Josh Beckerman
MYOS RENS Technology Inc. shares rose 32% to $1.17 after hours as the nutrition products company said it will merge with pharmacy organization MedAvail Inc. and spin out the MYOS muscle health business as a separate company.
MedAvail will pay the spun-out business $2 million in cash upon the closing of the merger and issue a promissory note for an additional $3 million.
MYOS owns Fortetropin, which helps build lean muscle.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
June 30, 2020 18:39 ET (22:39 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM